Volume 68 Received 8 February 2012 | ||||||||||
| ||||||||||
S][2,4,6-tris(pyridin-2-yl)-1,3,5-triazine-
3N1,N2,N6]zinc dioxane sesquisolvateaDepartment of Chemistry, The University of Texas at San Antonio, One UTSA Circle, San Antonio, Texas 78249-0698, USA,bChemical Abstracts Service, 2540 Olentangy River Road, Columbus, Ohio 43202, USA, and cDepartment of Chemistry, University of Malaya, 50603 Kuala Lumpur, Malaysia
Correspondence e-mail: edward.tiekink@gmail.com
The asymmetric unit of the title compound, [Zn(C4H8NOS2)2(C18H12N6)]·1.5C4H8O2, comprises a Zn-containing molecule and one and a half dioxane molecules as one of the solvent molecules is located about a crystallographic inversion centre. The approximately square-pyramidal N3S2 donor set is defined by two monodentate dithiocarbamate ligands and two pyridine and one triazine N atom from the tridentate triazine ligand. Molecules are connected into a supramolecular array via O-H
S and O-H
N hydrogen bonds. These stack along the b axis and the solvent molecules reside in the channels thus formed.
For background on structural studies on hydroxyl-substituted dithiocarbamate ligands, see: Benson et al. (2007
); Poplaukhin & Tiekink (2010
). For the coordination modes of triazine molecules, see: Therrin (2011
). For additional structural analysis, see: Addison et al. (1984
); Spek (2009
).
|
|
| ||||||||||||||
|
Data collection: CrystalClear (Molecular Structure Corporation & Rigaku, 2005
); cell refinement: CrystalClear; data reduction: CrystalClear; program(s) used to solve structure: SHELXS97 (Sheldrick, 2008
); program(s) used to refine structure: SHELXL97 (Sheldrick, 2008
); molecular graphics: ORTEP-3 (Farrugia, 1997
) and DIAMOND (Brandenburg, 2006
); software used to prepare material for publication: publCIF (Westrip, 2010
).
Supplementary data and figures for this paper are available from the IUCr electronic archives (Reference: LH5418 ).
We gratefully thank the Ministry of Higher Education (Malaysia) for funding structural studies through the High-Impact Research scheme (UM.C/HIR/MOHE/SC/12).
Addison, A. W., Rao, T. N., Reedijk, J., van Rijn, J. & Verschoor, G. C. (1984). J. Chem. Soc. Dalton Trans. pp. 1349-1356. ![[CrossRef]](../../../../../../logos/crossrefborder.gif)
Benson, R. E., Ellis, C. A., Lewis, C. E. & Tiekink, E. R. T. (2007). CrystEngComm, 9, 930-940.
![[ChemPort]](../../../../../../logos/chemportborder.gif)
Brandenburg, K. (2006). DIAMOND. Crystal Impact GbR, Bonn, Germany.
Farrugia, L. J. (1997). J. Appl. Cryst. 30, 565.
![[details]](../../../../../../j/graphics/details.gif)
Higashi, T. (1995). ABSCOR. Rigaku Corporation, Tokyo, Japan.
Molecular Structure Corporation & Rigaku (2005). CrystalClear. MSC, The Woodlands, Texas, USA, and Rigaku Corporation, Tokyo, Japan.
Poplaukhin, P. & Tiekink, E. R. T. (2010). CrystEngComm, 12, 1302-1306.
![[CrossRef]](../../../../../../logos/crossrefborder.gif)
Sheldrick, G. M. (2008). Acta Cryst. A64, 112-122.
![[details]](../../../../../../a/graphics/details.gif)
Spek, A. L. (2009). Acta Cryst. D65, 148-155.
![[details]](../../../../../../d/graphics/details.gif)
Therrin, B. (2011). J. Organomet. Chem. 696, 637-651.
Westrip, S. P. (2010). J. Appl. Cryst. 43, 920-925.
![[details]](../../../../../../j/graphics/details.gif)